Beijing Zhiyin Biomedical Technology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Beijing Zhiyin Biomedical Technology Co., Ltd. - overview
Established
2026
Location
Beijing, Beijing, China
Primary Industry
Biotechnology
About
Based in Beijing, China and founded in 2026, Beijing Zhiyin Biomed Technology Co. , Ltd. is an innovative biopharmaceutical company specializing in AI-powered cell reprogramming technologies. In September 2026, it raised tens of millions of CNY in Seed funding led by Shanxi Growth Enterprise Leading Fund.
Beijing Zhiyin Biomedical Technology Co. , Ltd. develops the proprietary iCellFate Cell Fate Programming Operating System, an integrated technology platform combining chemical reprogramming (CPiCR), RNA reprogramming (RNAiCR), and dCas9-based in vivo reprogramming (CRISPRiCR). These technologies enable the reprogramming of cell identity and cellular states through epigenetic regulation without modifying DNA sequences.
The company leverages artificial intelligence, high-throughput screening, molecular design technologies, and multi-omics data analysis to develop novel therapeutic candidates. The company generates revenue through the development and commercialization of cell therapy products, regenerative medicine therapies, technology licensing, and research collaborations. The company will use the Seed funding to support its preclinical research on core pipelines, IND filings, and the construction and equipment procurement for GMP laboratories, thereby accelerating the clinical translation of cell reprogramming technology.
Current Investors
Shanxi Growth Enterprise Leading Fund
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.